Potential drug-drug interactions and polypharmacy in institutionalized elderly patients in a public hospital in Brazil

被引:16
|
作者
Castilho, E. C. D. [1 ]
Reis, A. M. M. [2 ]
Borges, T. L. [1 ]
Siqueira, L. D. C. [3 ]
Miasso, A. I. [1 ]
机构
[1] Univ Sao Paulo, Ribeirao Preto Nursing Sch, Psychiat Nursing & Human Sci Dept, Ribeirao Preto, SP, Brazil
[2] Univ Fed Minas Gerais, Belo Horizonte, MG, Brazil
[3] Grande Dourados Univ Hosp, Dourados, MS, Brazil
关键词
aged; drug interactions; drug therapy; health of the elderly; patient safety; polypharmacy; MEDICATION RECONCILIATION; PSYCHIATRIC-PATIENTS; INAPPROPRIATE MEDICATIONS; PSYCHOTROPIC MEDICATIONS; COHORT; PREVALENCE; FLUOXETINE; ADMISSIONS; MANAGEMENT; PAROXETINE;
D O I
10.1111/jpm.12431
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
Accessible Summary What is known on the subject? Older individuals constitute an increasing proportion of the population, and therefore, are the major consumers of drugs. The elderly, especially those with mental disabilities, frequently develop chronic diseases and start using numerous drugs. Drug-drug interactions (DDIs) are a major clinical problem in the elderly population, and previous studies have focused only on antidepressants and others types of drugs used to treat mental health conditions. What this article adds to existing knowledge? This study shows that in hospitalized elderly patients with mental disorders (aged 60-69years), polypharmacy (5 drugs) and the use of drugs that act on the cardiovascular, respiratory and nervous systems can lead to potential drug-drug interactions. Moreover, it was reported that the prevalence of drug-drug interactions in elderly patients with mental disorders was high during their hospitalization in a public hospital in Brazil. What are the implications for practice? Nurses should know the factors associated with drug-drug interactions in hospitalized elderly patients with mental disorders to choose appropriate strategies for avoiding treatment failure and adverse events in patients. Abstract Introduction Despite the impact on patient safety and the fact that prevalence is higher in older patients, previous research did not analyse drug-drug interactions (DDIs) in view of nursing care of elderly psychiatric patients. Aim To identify potential drug-drug interactions and polypharmacy in prescriptions of aged inpatients with psychiatric disorders and analyse associated factors. Methods In this retrospective cross-sectional study, we analysed the medical records of institutionalized patients diagnosed with psychiatric disorders (n=94), aged >60years, and prescribed multiple medications. Drug prescriptions were checked at admission, midway through and the last prescription. Factors associated with DDI occurrence were assessed using multivariable logistic regression analysis. Results A DDI prevalence potential of 67.0%, 74.5% and 80.8% occurred in patients at admission, midway through hospitalization and the last prescription, respectively. Most of the prescribed drugs were nervous system agents. A high percentage of serious and contraindicated potential DDIs occurred. Age between 60 and 69years, use of cardiovascular and respiratory system drugs, and the number of medications contributed significantly to DDI. Implications for mental health nursing Knowledge on the factors associated with DDIs in patients with mental disorders can contribute to the improvement of effectiveness and safety of nursing care.
引用
收藏
页码:3 / 13
页数:11
相关论文
共 50 条
  • [31] Potential drug-drug interactions in outpatient lung cancer patients in a university hospital
    Demirkapu, Mahluga Jafarova
    Cavdar, Eyyup
    PHARMACOLOGY, 2024, 109 (04) : 231 - 236
  • [32] Drug-Drug Interactions in Hepatitis Patients: Do these Interactions Matter in Clinical Perspectives?
    Noor, Sidra
    Ismail, Mohammad
    Haider, Iqbal
    Khadim, Faiza
    ANNALS OF HEPATOLOGY, 2018, 17 (06) : 1001 - 1011
  • [33] Potential drug interactions in elderly cancer patients
    Girre, V.
    Arkoub, H.
    Puts, M. T. E.
    Vantelon, C.
    Blanchard, F.
    Droz, J. P.
    Mignot, L.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2011, 78 (03) : 220 - 226
  • [34] The Prevalence of Polypharmacy and Potential Drug-Drug Interactions among Iranian Cancer Patients: Which Patients were at Risk?
    Bazrafshani, Maliheh Sadat
    Pardakhty, Abbas
    Khandani, Behjat Kalantari
    Nasiri, Naser
    Moghaderi, Masoud
    Bazrafshani, Azam
    Mehmandoost, Soheil
    Beigzadeh, Amin
    Sharifi, Hamid
    CANCER INVESTIGATION, 2022, 40 (05) : 457 - 472
  • [35] Incidence of Potential Drug-Drug Interactions in Patients with Cardiovascular Complications Due to the Trend of Polypharmacy Prescription in Pakistan
    Javaid, Farah
    Hanif, Sana
    Syed, Muhammad Ali
    Jawad, Saqib
    Afzal, Sara
    Malik, Ramsha
    Ashraf, Swaiba
    Khan, Iqra
    LATIN AMERICAN JOURNAL OF PHARMACY, 2017, 36 (06): : 1210 - 1217
  • [36] The prevalence and severity of potential drug-drug interactions among adult polypharmacy patients at outpatient clinics in Jordan
    Nusair, Mohammad B.
    Al-Azzam, Sayer, I
    Arabyat, Rasha M.
    Amawi, Haneen A.
    Alzoubi, Karem H.
    Rabah, Asma A.
    SAUDI PHARMACEUTICAL JOURNAL, 2020, 28 (02) : 155 - 160
  • [37] Potential drug-drug interactions in cardiology ward of a teaching hospital
    Ismail, Mohammad
    Iqbal, Zafar
    Khattak, Muhammad Bilal
    Khan, Muhammad Imran
    Javaid, Arshad
    Khan, Tahir Mehmood
    HEALTHMED, 2012, 6 (05): : 1618 - 1624
  • [38] Mild polypharmacy and MCI progression in older adults: the mediation effect of drug-drug interactions
    Trevisan, Caterina
    Limongi, Federica
    Siviero, Paola
    Noale, Marianna
    Cignarella, Andrea
    Manzato, Enzo
    Sergi, Giuseppe
    Maggi, Stefania
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2021, 33 (01) : 49 - 56
  • [39] Potential Drug-Drug Interactions in Patients With Urinary Tract Infections: A Contributing Factor in Patient and Medication Safety
    Noor, Sidra
    Ismail, Mohammad
    Khan, Fahadullah
    FRONTIERS IN PHARMACOLOGY, 2019, 10
  • [40] Potential drug-drug interactions associated with adverse clinical outcomes and abnormal laboratory findings in patients with malaria
    Noor, Sidra
    Ismail, Mohammad
    Khadim, Faiza
    MALARIA JOURNAL, 2020, 19 (01)